Garde Capital, Inc. Abbott Laboratories Transaction History

Garde Capital, Inc.

$1.52 Billion
Q3 2024

A detailed history of Garde Capital, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Garde Capital, Inc. holds 1,165 shares of ABT stock, worth $133,695. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,165

Previous 1,554 25.03%

Holding current value

$133,695

Previous $161,000 17.39%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 03, 2024	SELL	$100.07 - $118.13 $38,927 - $45,952	-389 Reduced 25.03%	1,165 $133,000
Q1 2024 May 29, 2024	SELL	$109.52 - $120.96 $33,294 - $36,771	-304 Reduced 16.36%	1,554 $176,000
Q4 2023 Feb 21, 2024	BUY	$90.19 - $110.4 $23,629 - $28,924	262 Added 16.42%	1,858 $205,000
Q3 2023 Nov 17, 2023	BUY	$95.53 - $114.62 $2,388 - $2,865	25 Added 1.59%	1,596 $155,000
Q2 2023 Aug 28, 2023	SELL	$100.78 - $112.29 $8,969 - $9,993	-89 Reduced 5.36%	1,571 $171,000
Q1 2023 May 24, 2023	SELL	$96.86 - $114.01 $12,204 - $14,365	-126 Reduced 7.05%	1,660 $168,000
Q4 2022 Feb 24, 2023	BUY	$95.06 - $111.52 $15,209 - $17,843	160 Added 9.84%	1,786 $196,000
Q2 2022 Aug 23, 2022	SELL	$102.07 - $123.37 $59,200 - $71,554	-580 Reduced 26.29%	1,626 $177,000
Q4 2021 Feb 25, 2022	BUY	$115.53 - $141.46 $17,098 - $20,936	148 Added 7.19%	2,206 $311,000
Q3 2021 Nov 17, 2021	BUY	$116.66 - $129.06 $61,713 - $68,272	529 Added 34.6%	2,058 $243,000
Q2 2021 Aug 19, 2021	BUY	$105.79 - $124.53 $105 - $124	1 Added 0.07%	1,529 $177,000
Q1 2021 May 24, 2021	BUY	$108.84 - $128.23 $21,876 - $25,774	201 Added 15.15%	1,528 $183,000
Q4 2020 Feb 26, 2021	BUY	$105.0 - $114.42 $139,335 - $151,835	1,327 New	1,327 $145,000
Q1 2019 May 08, 2019	SELL	$66.22 - $80.06 $620,812 - $750,562	-9,375 Closed	0 $0
Q2 2018 Aug 20, 2018	BUY	$57.57 - $63.54 $4,317 - $4,765	75 Added 0.81%	9,375 $572,000
Q1 2018 May 16, 2018	SELL	$56.27 - $63.62 $8,440 - $9,543	-150 Reduced 1.59%	9,300 $557,000
Q4 2017 Feb 23, 2018	SELL	$53.68 - $57.47 $74,883 - $80,170	-1,395 Reduced 12.86%	9,450 $539,000
Q3 2017 Nov 17, 2017	BUY	$48.06 - $53.64 $521,210 - $581,725	10,845	10,845 $579,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Garde Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Garde Capital, Inc. with notifications on news.

Account

Garde Capital, Inc. Abbott Laboratories Transaction History